{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T19:47:14Z","timestamp":1774295234083,"version":"3.50.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00216","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T05:20:32Z","timestamp":1552972832000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6"],"prefix":"10.3389","volume":"10","author":[{"given":"Nicole E.","family":"James","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Cantillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael B.","family":"Rowswell-Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu-Kwang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Clinton O.","family":"Chichester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"DiSilvestro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard G.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting C.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1007\/s13277-014-1836-x","article-title":"Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer?","volume":"35","author":"Angioli","year":"2014","journal-title":"Tumor Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"C189","DOI":"10.1152\/ajpcell.00347.2009","article-title":"The dual-specificity MAP kinase phosphatases: critical roles in development and cancer","volume":"299","author":"Bermudez","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/mi.2014.84","article-title":"Dual-specificity phosphatase 6 regulates CD4+ T-cell functions and restrains spontaneous colitis in IL-10-deficient mice","volume":"8","author":"Bertin","year":"2015","journal-title":"Mucosal. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1038\/sj.onc.1205363","article-title":"The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms","volume":"21","author":"Bingle","year":"2002","journal-title":"Oncogene"},{"key":"B5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1093\/carcin\/bgn167","article-title":"Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells","volume":"29","author":"Chan","year":"2008","journal-title":"Carcinogenesis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/1471-2164-10-261","article-title":"Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal","volume":"10","author":"Chechlinska","year":"2009","journal-title":"BMC Genomics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1757-2215-7-62","article-title":"Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer","volume":"7","author":"Chudecka-G\u0142az","year":"2014","journal-title":"J. Ovarian Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1073\/pnas.0915174107","article-title":"PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors","volume":"107","author":"Curran","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/modpathol.3800383","article-title":"Distinct progression pathways involving the dysfunction of DUSP6\/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas","volume":"18","author":"Furukawa","year":"2005","journal-title":"Mod. Pathol."},{"key":"B11","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstr\u00f6m","year":"2003","journal-title":"Cancer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1084\/jem.20130066","article-title":"Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4","volume":"210","author":"Holmgaard","year":"2013","journal-title":"J. Exp. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12979-017-0096-1","article-title":"pERK-dependent defective TCR-mediated activation of CD4+ T cells in end-stage renal disease patients","volume":"14","author":"Huang","year":"2017","journal-title":"Immun. Ageing."},{"key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1756-9966-31-14","article-title":"Therapeutic strategies in epithelial ovarian cancer","volume":"31","author":"Kim","year":"2012","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/intimm\/dxh283","article-title":"Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes","volume":"17","author":"Kovanen","year":"2005","journal-title":"Int. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/jog.13181","article-title":"Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer","volume":"43","author":"Lee","year":"2017","journal-title":"J. Obs. Gynaecol. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/nm.2963","article-title":"Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity","volume":"18","author":"Li","year":"2012","journal-title":"Nat. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1038\/srep05500","article-title":"HE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocation","volume":"4","author":"Lokich","year":"2014","journal-title":"Sci. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbrc.2012.02.008","article-title":"Human epididymis protein 4 (HE4) plays a key role in ovarian cancer cell adhesion and motility","volume":"419","author":"Lu","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/CLO-2010-0520","article-title":"Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors","volume":"32","author":"Lucci","year":"2010","journal-title":"Cell Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1038\/onc.2011.99","article-title":"Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas","volume":"30","author":"Messina","year":"2011","journal-title":"Oncogene"},{"key":"B22","doi-asserted-by":"publisher","first-page":"E1169","DOI":"10.3390\/ijms17071169","article-title":"Immune checkpoint inhibitors: a new opportunity in the treatment of ovarian cancer?","volume":"17","author":"Mittica","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1038\/srep03574","article-title":"HE4 (WFDC2) gene overexpression promotes ovarian tumor growth","volume":"4","author":"Moore","year":"2014","journal-title":"Sci. Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"351.e1","DOI":"10.1016\/j.ajog.2011.12.029","article-title":"Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders","volume":"206","author":"Moore","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2353\/ajpath.2009.080489","article-title":"Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis","volume":"175","author":"Okudela","year":"2009","journal-title":"Am. J. Pathol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13048-016-0240-0","article-title":"HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells","volume":"9","author":"Ribeiro","year":"2016","journal-title":"J. Ovarian Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1007\/s12032-011-0137-0","article-title":"Anti-Sp17 monoclonal antibody with antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity activities against human ovarian cancer cells","volume":"29","author":"Song","year":"2012","journal-title":"Med. Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"12389","DOI":"10.1007\/s13277-014-2553-1","article-title":"Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer","volume":"35","author":"Vallius","year":"2014","journal-title":"Tum. Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jaad.2017.04.1126","article-title":"The new paradigm of systemic therapies for metastatic melanoma","volume":"77","author":"Volpe","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3892\/or.2014.3549","article-title":"Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells","volume":"33","author":"Wang","year":"2015","journal-title":"Oncol. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrc2583","article-title":"Beyond chemotherapy: targeted therapies in ovarian cancer","volume":"9","author":"Yap","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pharmthera.2017.07.004","article-title":"Oncogenic pathways that affect antitumor immune response and immune checkpoint blockade therapy","volume":"181","author":"Zhao","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"729","DOI":"10.18632\/oncotarget.6327","article-title":"Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer","volume":"7","author":"Zhu","year":"2016","journal-title":"Oncotarget"},{"key":"B35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1995-7645(13)60055-3","article-title":"Effect of WFDC 2 silencing on the proliferation, motility and invasion of human serous ovarian cancer cells in vitro","volume":"6","author":"Zhu","year":"2013","journal-title":"Asian Pac. J. Trop. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e68994","DOI":"10.1371\/journal.pone.0068994","article-title":"Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma","volume":"8","author":"Zhuang","year":"2013","journal-title":"PLoS ONE"},{"key":"B37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.biochi.2014.06.022","article-title":"Overexpression of Lewis y antigen promotes human epididymis protein4-mediated invasion and metastasis of ovarian cancer cells","volume":"105","author":"Zhuang","year":"2014","journal-title":"Biochimie"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00216\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T05:20:34Z","timestamp":1552972834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00216\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":37,"alternative-id":["10.3389\/fphar.2019.00216"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00216","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]},"article-number":"216"}}